BioSpace News Archive

December 3, 2024

Roche Partners With COUR in Autoimmune Deal Potentially Worth More Than $900M

The collaboration will see COUR and Roche’s Genentech leverage the biotech’s antigen-specific immune tolerance platform to develop and commercialize therapies for an undisclosed autoimmune disease.

December 3, 2024

·

1 min read

·

Heather McKenzie

Deerfield - Circa June 2019: Takeda Pharmaceutical Company. Takeda recently acquired Irish drugmaker Shire I

Collaboration

Takeda Puts Up to $1.3B on the Line for Keros’ Blood Cancer Anemia Drug

Keros’ elritercept has shown promising efficacy signals in myelofibrosis and myelodysplastic syndromes and could pose a formidable challenge to Bristol Myers Squibb’s Reblozyl.

December 3, 2024

·

2 min read

·

Tristan Manalac

Antibody-drug conjugate

Gilead Plots ADC Comeback With Potential $415M License Agreement

The deal with Tubulis will help Gilead regain its footing in the ADC space following the withdrawal of Trodelvy in bladder cancer and its late-stage fail in NSCLC.

December 3, 2024

·

2 min read

·

Tristan Manalac

Photo of dragon statue and students at Drexel University

Partnered

Making the Grade: Drexel’s Biomedical Sciences Programs Boost Careers at All Stages

At Drexel University’s Graduate School of Biomedical Sciences and Professional Studies, graduate students and active professionals can take interdisciplinary, career-oriented programs designed to help launch their careers and take them to the next level.

December 3, 2024

·

5 min read

·

BioSpace Insights

Businessman jump careful on cracked or broken graph. Job opportunity and career. concept of under pressure. risk, financial, and tax

Layoffs

Alligator Axes 70% of Staff Amid ‘Capital Constraints,’ Renews Pancreatic Cancer Focus

Alongside the layoffs, Alligator will also suspend work on all of its earlier-stage assets and devote its resources to lead candidate mitazalimab, being developed for the frontline treatment of metastatic pancreatic cancer.

December 3, 2024

·

2 min read

·

Tristan Manalac

Pill with human brains on isolated pastel pink background. Minimal abstract concept. Lack of wisdom and memory or treatment psychiatric or psychological disorders. Creative idea of mental illness or health care. Flat lay.

Neuroscience

Intra-Cellular Eyes Depression Approval for Caplyta as Stock Flies Under the Radar

Intra-Cellular submitted its application to the FDA for Caplyta’s approval in major depressive disorder, potentially opening up an additional $1 billion in sales. Still, the stock remains “cheap,” according to Jefferies analysts.

December 3, 2024

·

4 min read

·

Annalee Armstrong

Press Releases

Novo Nordisk to present new data from sickle cell disease and haemophilia trials at the 66th American Society of Hematology (ASH) annual meeting

December 3, 2024

·

7 min read

Press Releases

Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants